CSPP1 Antibody

What is CSPP1 and what are its key cellular functions?

CSPP1 is a 141 kDa protein that interacts with centrosomes and microtubules, playing crucial roles in:

• Cell-cycle progression and spindle organization

• Regulation of microtubule dynamics by capping both plus and minus ends

• Formation of a ternary complex with Nephrocystin 8 (NPHP8/RPGRIP1L) and NPHP4

• Ciliogenesis in various cell types

• Chromosome oscillation and segregation during mitosis

Recent research has revealed that CSPP1 functions as a novel microtubule end capping protein that stabilizes microtubules by suppressing catastrophe and restricting growth rates .

What applications have been validated for CSPP1 antibodies?

CSPP1 antibodies have been validated in multiple experimental applications:

Most commercially available antibodies show reactivity with human, mouse, and rat samples .

What are the recommended dilutions for CSPP1 antibodies in different applications?

The optimal dilution varies by application and specific antibody:

It is strongly recommended to titrate the antibody in each testing system to obtain optimal results, as the appropriate dilution may be sample-dependent .

How should CSPP1 antibodies be stored for optimal performance?

For most CSPP1 antibodies, the following storage conditions are recommended:

• Temperature: -20°C

• Typical storage buffer: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3

• Stability: Generally stable for one year after shipment

• Aliquoting: Often unnecessary for -20°C storage, though this may vary by product

• For fluorescently conjugated antibodies (e.g., CoraLite® Plus 488): Avoid exposure to light

Some formulations may contain additional components like BSA or Proclin300 as stabilizers.

How can CSPP1 antibodies be optimized for detecting the protein at microtubule ends?

Detecting CSPP1 at microtubule ends presents specific technical challenges:

• Expression level considerations: CSPP1 shows differential localization based on expression levels. At high expression, it exhibits non-specific binding to the MT lattice, masking tip associations. At lower expression levels closer to endogenous conditions, it specifically associates with MT ends .

• Signal intensity differences: The signal intensity of CSPP1 at microtubule tips is estimated to be several hundred times lower than at centrosomes, requiring:

  • Careful titration of antibody concentrations

  • Enhanced signal detection methods

  • Controlled expression of tagged proteins

• Technical approach: For visualizing endogenous CSPP1 at MT ends, consider:

  • Using a siRNA-resistant GFP-tagged CSPP1 construct expressed at near-endogenous levels

  • Imaging with enhanced power settings specifically for detecting MT tip localization

  • Being aware that antibody epitopes at MT ends may be masked by protein-protein interactions or fixation protocols

What experimental approaches can be used to study CSPP1's role in microtubule stabilization?

CSPP1's function in microtubule stabilization can be investigated through several complementary approaches:

• Domain-specific analysis: CSPP1's MT-associated domains have different functional properties:

  • Full-length CSPP1: Complete catastrophe suppression at 20 nM

  • CSPP1-M domain: Catastrophe suppression at 50 nM

  • CSPP1-M1 domain: Catastrophe suppression at 500 nM

  • CSPP1-M2 domain: Catastrophe suppression at 1 μM; shows prominent MT plus end tracking

• In vitro MT dynamics assays:

  • Measure MT growth rates in the presence of different CSPP1 concentrations

  • Quantify catastrophe frequency with purified proteins

  • Compare activities of full-length vs. truncated CSPP1 domains

How can CSPP1 antibodies be used in cancer research, particularly in breast cancer studies?

CSPP1 has shown potential as a biomarker in breast cancer research:

• Subcellular localization analysis:

  • Nuclear CSPP1 expression defines specific subtypes of basal-like breast carcinomas

  • Nuclear CSPP1-positive tumors display distinct luminal traits compared to nuclear CSPP1-negative counterparts

• Methodology for immunohistochemical analysis:

  • Tissue preparation: 5 μm sections from formalin-fixed, paraffin-embedded tissue

  • Antigen retrieval: Pressure cooking in 0.01 M citrate buffer

  • Detection: Antibody visualization using Envision+peroxidase system

  • Scoring: Semi-quantitative assessment of localization and intensity

  • Validation: Multiple cores per sample with consensus scoring between observers

• Correlation with genomic data:

  • CSPP1 expression correlates with DNA copy number variation (quantified by Pearson correlation)

  • Integration with gene expression microarray data using statistical analysis of microarray (SAM)

  • Survival analysis using Kaplan-Meier curves with breast cancer-specific death as endpoint

What are the best practices for studying CSPP1's interaction with kinetochore proteins?

To investigate CSPP1's role in chromosome segregation through its interaction with kinetochore proteins:

• Interaction verification approaches:

  • In-house antibody generation for endogenous CSPP1 localization at kinetochores

  • Co-immunoprecipitation of CSPP1 with kinetochore components like CENP-H

  • GST-pulldown assays with purified proteins

• Functional analysis methods:

  • siRNA-mediated CSPP1 depletion followed by mitotic progression analysis

  • Measurement of chromosome oscillation parameters in CSPP1-depleted cells

  • Quantification of kinetochore movement velocity with and without CSPP1

  • Specific perturbation of protein interactions using membrane-permeable competing peptides

What methodological considerations are important when validating CSPP1 knockdown or knockout experiments?

When designing CSPP1 loss-of-function studies:

• Knockdown validation approaches:

  • Western blot verification using validated CSPP1 antibodies (1:500-1:1000 dilution)

  • Immunofluorescence analysis to confirm cellular localization changes

  • qRT-PCR for mRNA level quantification

• Rescue experiments:

  • Design siRNA-resistant CSPP1 constructs (GFP-CSPP1res) by introducing silent mutations

  • Express rescue constructs at near-endogenous levels (typically 50 ng plasmid)

  • Verify expression levels by comparing to endogenous CSPP1 in control cells

  • Assess functional rescue through key phenotypic readouts (microtubule dynamics, cell division, cilia formation)

• Phenotypic analysis considerations:

  • Assess multiple cellular processes where CSPP1 functions:

    • Microtubule stability and dynamics

    • Centrosome and spindle pole organization

    • Cilium formation

    • Chromosome segregation

    • Cell cycle progression

How can fluorescently conjugated CSPP1 antibodies be optimized for live-cell imaging studies?

For live-cell imaging with fluorescent CSPP1 antibodies:

• Antibody selection:

  • CoraLite® Plus 488-conjugated CSPP1 antibodies (Excitation/Emission: 493 nm/522 nm)

  • Recommended dilution for IF/ICC: 1:50-1:500

• Optimization considerations:

  • Titrate antibody concentration to minimize background while maintaining specific signal

  • Consider using specialized cell-permeable variants for live-cell applications

  • For fixed-cell applications, optimize fixation methods to preserve epitope accessibility

  • Control for potential artifacts by comparing with unconjugated antibody staining patterns

• Technical parameters:

  • Storage: -20°C, avoiding light exposure

  • Buffer composition: PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3

  • Sample types validated: HeLa cells (particularly effective)

What are the experimental considerations for studying CSPP1's dual role in centrosomes and microtubule dynamics?

CSPP1's dual localization at centrosomes and microtubule ends requires specialized approaches:

• Differential localization analysis:

  • Use super-resolution microscopy to distinguish centrosomal vs. microtubule-associated pools

  • Employ domain-specific antibodies or truncation constructs to map functional regions

  • For live-cell imaging, consider dual-color approaches with centrosome markers

• Centrosome-specific functions:

  • Assess CSPP1's interaction with Nephrocystin 8 (NPHP8/RPGRIP1L) and NPHP4

  • Investigate ciliogenesis in relevant cell types (hTERT-RPE1 cells)

  • Examine expression in ciliated renal, retinal, and respiratory cells in vivo

• Microtubule-specific analysis:

  • Purify CSPP1 domains for in vitro MT polymerization assays

  • Characterize MT growth rates and catastrophe frequencies

  • Compare activity of different CSPP1 domains (M, M1, M2) to understand structure-function relationships

How can researchers address technical challenges in detecting low-abundance CSPP1 at specific subcellular locations?

Detecting trace amounts of CSPP1 at specific subcellular locations requires specialized approaches:

• Signal enhancement strategies:

  • Signal amplification using tyramide signal amplification (TSA)

  • Super-resolution microscopy techniques (STED, STORM, SIM)

  • Enhanced camera sensitivity and longer exposure times with appropriate controls

• Epitope accessibility considerations:

  • Test multiple fixation protocols to identify optimal epitope preservation

  • Consider epitope masking by interacting proteins at specific locations

  • Use multiple antibodies targeting different regions of CSPP1

• Expression system considerations:

  • Use inducible expression systems for tight control of exogenous CSPP1 levels

  • Carefully quantify expression relative to endogenous levels

  • Design domain-specific constructs for targeting particular functions

The significant difference in signal intensity between centrosomal CSPP1 (very bright) and microtubule tip-associated CSPP1 (hundreds of times dimmer) necessitates these specialized approaches for comprehensive analysis of CSPP1's diverse cellular functions .